Why the Buzz Over Toenails?

February 2, 2015

Why the Buzz over Toenails?

Why the Buzz Over Toenails?

With 35 million Americans potentially suffering from toenail fungus – sometimes painful, always ugly – it’s no wonder that the recent medical breakthrough making waves is a new topical cure.

Those battling Onychomycosis (on-ick-oh-my-CO-sis) of the toenail might report a thickening of the nail, discoloration, brittleness, and crumbling, and even a painful lifting of the nail from the skin. Under the toenail, the infection is hard to reach and difficult to treat. Until now, patients have had to take oral antifungals for up to 6 months, sometimes combined with a topical treatment, to eliminate it.

And even then, positive results are not guaranteed.

No more.

Toenail Treatment Options in Denver, Colorado

U.S. Dermatology Partners Littleton, formerly Apex Dermatology Group, excited to offer two new FDA-approved topical products that achieve a cure on their own: Jublia and Kerydin.

  • Jublia (efinaconazole) Topical Solution 10% (http://www.jubliarx.com) by Valeant Pharmaceuticals is applied daily for 48 weeks. In two separate studies, more than 53% of patients using Jublia tested fungus-free after one year.  That’s a big improvement over previous options.
  • Kerydin (http://www.kerydin.com) by PharmaDerm is also applied daily for 48 weeks with similar results.

The important thing? No blood tests or liver function monitoring required. And as the 35 million battling Onychomycosis know, that’s something to buzz about.

So if you want to slip into flip-flops this summer…

Or you’re longing to gloss on your Bogota Blackberry or Chick Flick Cherry after years of “no polish!”…

Booking Your Next Toenail Appointment

To start your proven toenail treatment at our Littleton or Denver office, please schedule an appointment at U.S. Dermatology Partners. Call our Denver office at (303) 261-1525 or our Littleton office at (303) 795-2030.

Find a location